Laird Norton Wetherby Wealth Management LLC Sells 905 Shares of Agilent Technologies, Inc. (NYSE:A)

Laird Norton Wetherby Wealth Management LLC lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 11.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,149 shares of the medical research company’s stock after selling 905 shares during the quarter. Laird Norton Wetherby Wealth Management LLC’s holdings in Agilent Technologies were worth $960,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. CKW Financial Group increased its position in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after purchasing an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares during the period. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $29,000. Finally, Hanson & Doremus Investment Management lifted its holdings in Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after buying an additional 105 shares during the period.

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. The trade was a 4.84% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Stock Performance

Shares of A stock opened at $111.49 on Thursday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35. The company’s 50 day moving average price is $110.78 and its two-hundred day moving average price is $128.45. The company has a market capitalization of $31.79 billion, a P/E ratio of 25.63, a price-to-earnings-growth ratio of 3.25 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. On average, analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were paid a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.89%. The ex-dividend date was Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is 22.76%.

Wall Street Analyst Weigh In

A number of analysts have commented on A shares. Robert W. Baird lowered their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Wells Fargo & Company reduced their price target on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. TD Cowen upped their price objective on Agilent Technologies to $135.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research note on Monday, April 21st. Finally, Barclays decreased their target price on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $143.00.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.